chevron_leftBack
As of 24 April 2025, PT Kimia Farma Tbk has a market cap of $140.02M USD, ranking #18996 globally and #286 in Indonesia. It ranks #1893 in the Healthcare sector, and #50 in the Medical Distribution industry.
Key Stats
Market Cap
$140.02MUSD
2.36T IDR
Enterprise Value
$593.91MUSD
10.01T IDR
Revenue (TTM)
$600.02MUSD
10.11T IDR
EBITDA (TTM)
-$91.18MUSD
-1.54T IDR
Net Income (TTM)
-$102.63MUSD
-1.73T IDR
EBITDA Margin
-15%
Profit Margin
-17%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
David Utama
open_in_new
Employees
11,461
Founded
1817
Website
kimiafarma.co.id
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.5% | 2.4% | 10% | -31% | -41% | -43% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
KAEF
PT Kimia Farma Tbk Class B
ISIN: ID1000070303
Shares Out.:
Shares Outstanding:
5.567B1
Shares Float:
277.172M2
|
426.00 IDR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About PT Kimia Farma Tbk
PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products in Indonesia. It also provides generic, ethical, license and narcotic medicines, over the counter medicines, raw materials, medicines, medical devices, and cosmetic products, as well as rapid test diagnostic tools. In addition, the company is involved manufacturing and marketing of pharmaceutical raw materials and active pharmaceutical ingredients; health foods and effervescent tablets; quinine salt and related derivatives; and castor oil and edible oil. Further, it retails and distributes pharmaceutical products. The company exports its products to Asia, Europe, Australia, Africa, and the United States. PT Kimia Farma Tbk was founded in 1817 and is headquartered in Jakarta, Indonesia.
